Dengue Rapid Tests Market

Dengue Rapid Tests: Overview

According to the latest research by PMR, Dengue Rapid Tests are set to witness a steady-paced growth of CAGR 5.4 % during the year 2021-2031. Dengue rapid tests are increasingly used as a swift approach to confirm recent dengue infections. The impact of such rapid and early confirmations of dengue infections leads to assisted strength in disease surveillance programs and therefore, result in successful vector control measures.

Dengue rapid tests are expected to witness a swift growth in adoption over the forecast period due to their short turnaround time and ease of use. Furthermore, the growth in adoption of dengue rapid tests is also expected to be driven due to COVID-19 infections, the symptoms of which are similar to the infections caused by the dengue virus in the early stages.

What is Driving Demand for Dengue Rapid Tests?

The demand for dengue rapid tests is increasing due to the growing incidences of dengue-related infections. According to WHO (Revised data - 2021), there are an estimated 100-400 million dengue associated infections each year, which account for over half the world’s population.

Effective vector control measures are associated with the early detection of dengue infections, thus, the use of dengue rapid kits is gaining propulsion. This is further aided by the low cost and reliability of the test kits as well as the increasing disposition of awareness programs for controlling the spread of dengue.

Additionally, the growing demand for dengue rapid tests is also favored by the spread of dengue related infections across the globe. This is due to the climate change phenomenon and abnormal weather events associated with it leading to an increased global burden, which is over 8 fold increase over the last two decades as per WHO.

Which factors are likely to augment growth of Dengue Rapid Tests?

The threat of dengue has grown over the past few decades and is expected to rise. The factors which are likely to augment the adoption of dengue rapid tests are the increasing amount of travel between urban and rural areas and intercontinental travel and the rising threat of global warming.

These factors result in the spread of viral vectors. Thus, the detection of infections by dengue rapid test kits is a prime step in the management of public health by control of disease after its early stage detection.

U.S. and Canada Dengue Rapid Tests Outlook:

The region of North America is expected to grow at a significant rate over the forecast period. The factors aiding this growth are the presence of key and leading market players in the region in addition to a developed healthcare infrastructure.

According to the CDC, dengue outbreaks most recently occurred in Florida (2020) and Texas (2015) in the U.S. The prevalence of dengue fever is rare in Canada, but it is expected to witness a rise in cases due to international travel as well as climate change.

Europe Demand Outlook for Dengue Rapid Tests:

The region of Europe is anticipated to occupy a large share in the adoption of dengue rapid tests due to the rising infections and risks associated with dengue due to changing climatic conditions over the forecast period. The growth is also evaluated by the presence of growing advancements in healthcare in the region.

According to the WHO factsheet (2021), Europe is a potential region for a possible dengue outbreak. Moreover, over 25 countries in the region have witnessed a spread of dengue vector by 2021, which was associated with international trade of used tires and other products that act as a breeding ground for the dengue mosquito.

Who are the Key Manufacturers and Suppliers of Dengue Rapid Tests?

The key companies operating in manufacturing and supply of Dengue Rapid Tests are

• Abbott Laboratories
• OriGene Technologies Inc.
• Euroimmun AG
• InBios International
• NovaTec Immundiagnostica GmbH
• Abnova Corporation Inc.
• Quest Diagnostics Inc.
• DiaSorin Group
• Roche Molecular Systems Inc.
• Certest Biotec S.L.
• Thermo Fisher Scientific Inc.
• InBios International Inc.

Key Segments:

By Test Type

• ELISA-Based Test
• NS1-Rapid Dengue Test
• RT-PCR Amplification Assay
• Dengue IgG/IgM Rapid Test
• Others

By End-User

• Medical Hospitals
• Diagnostic Centers
• Others

By Region

• North America
  • US
  • Canada
• Latin America
  • Brazil
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • BENELUX
  • Russia
• South Asia
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Rest of South Asia
• East Asia
  • China
  • Japan
  • South Korea
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Turkey

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Dengue Rapid Tests Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

To know more about delivery timeline for this report Contact Sales